ResearchIn-Press PreviewEndocrinologyGenetics
Open Access | 10.1172/jci.insight.170884
1Stanford University School of Medicine, Stanford, United States of America
2Department of Developmental Biology, Stanford University School of Medicine, Stanford, United States of America
3Department of Pharmacology, The University of Alberta, Edmonton, Canada
4Alberta Diabetes Institute, The University of Alberta, Edmonton, Canada
Find articles by Qian, M. in: JCI | PubMed | Google Scholar
1Stanford University School of Medicine, Stanford, United States of America
2Department of Developmental Biology, Stanford University School of Medicine, Stanford, United States of America
3Department of Pharmacology, The University of Alberta, Edmonton, Canada
4Alberta Diabetes Institute, The University of Alberta, Edmonton, Canada
Find articles by Bevacqua, R. in: JCI | PubMed | Google Scholar
1Stanford University School of Medicine, Stanford, United States of America
2Department of Developmental Biology, Stanford University School of Medicine, Stanford, United States of America
3Department of Pharmacology, The University of Alberta, Edmonton, Canada
4Alberta Diabetes Institute, The University of Alberta, Edmonton, Canada
Find articles by Coykendall, V. in: JCI | PubMed | Google Scholar
1Stanford University School of Medicine, Stanford, United States of America
2Department of Developmental Biology, Stanford University School of Medicine, Stanford, United States of America
3Department of Pharmacology, The University of Alberta, Edmonton, Canada
4Alberta Diabetes Institute, The University of Alberta, Edmonton, Canada
Find articles by
Liu, X.
in:
JCI
|
PubMed
|
Google Scholar
|
1Stanford University School of Medicine, Stanford, United States of America
2Department of Developmental Biology, Stanford University School of Medicine, Stanford, United States of America
3Department of Pharmacology, The University of Alberta, Edmonton, Canada
4Alberta Diabetes Institute, The University of Alberta, Edmonton, Canada
Find articles by Zhao, W. in: JCI | PubMed | Google Scholar
1Stanford University School of Medicine, Stanford, United States of America
2Department of Developmental Biology, Stanford University School of Medicine, Stanford, United States of America
3Department of Pharmacology, The University of Alberta, Edmonton, Canada
4Alberta Diabetes Institute, The University of Alberta, Edmonton, Canada
Find articles by Chang, C. in: JCI | PubMed | Google Scholar
1Stanford University School of Medicine, Stanford, United States of America
2Department of Developmental Biology, Stanford University School of Medicine, Stanford, United States of America
3Department of Pharmacology, The University of Alberta, Edmonton, Canada
4Alberta Diabetes Institute, The University of Alberta, Edmonton, Canada
Find articles by Gu, X. in: JCI | PubMed | Google Scholar
1Stanford University School of Medicine, Stanford, United States of America
2Department of Developmental Biology, Stanford University School of Medicine, Stanford, United States of America
3Department of Pharmacology, The University of Alberta, Edmonton, Canada
4Alberta Diabetes Institute, The University of Alberta, Edmonton, Canada
Find articles by Dai, X. in: JCI | PubMed | Google Scholar
1Stanford University School of Medicine, Stanford, United States of America
2Department of Developmental Biology, Stanford University School of Medicine, Stanford, United States of America
3Department of Pharmacology, The University of Alberta, Edmonton, Canada
4Alberta Diabetes Institute, The University of Alberta, Edmonton, Canada
Find articles by
MacDonald, P.
in:
JCI
|
PubMed
|
Google Scholar
|
1Stanford University School of Medicine, Stanford, United States of America
2Department of Developmental Biology, Stanford University School of Medicine, Stanford, United States of America
3Department of Pharmacology, The University of Alberta, Edmonton, Canada
4Alberta Diabetes Institute, The University of Alberta, Edmonton, Canada
Find articles by Kim, S. in: JCI | PubMed | Google Scholar
Published November 9, 2023 - More info
HNF1A haploinsufficiency underlies the most common form of human monogenic diabetes (HNF1A-MODY) and hypomorphic HNF1A variants confer type 2 diabetes risk, but a lack of experimental systems for interrogating mature human islets has limited our understanding of how the transcription factor HNF1α regulates adult islet function. Here, we combined conditional genetic targeting in human islet cells, RNA sequencing, chromatin mapping with Cleavage Under Targets & Release Using Nuclease (CUT&RUN), and transplantation-based assays to determine HNF1α-regulated mechanisms in adult human pancreatic α and β cells. Short hairpin RNA-mediated (shRNA) suppression of HNF1A in primary human pseudoislets led to blunted insulin output and dysregulated glucagon secretion after transplantation in mice, recapitulating phenotypes observed in diabetic patients. These deficits corresponded with altered expression of genes encoding factors critical for hormone secretion, including calcium channel subunits, ATPase transporters and extracellular matrix constituents. Additionally, HNF1A loss led to upregulation of transcriptional repressors, providing evidence for a mechanism of transcriptional de-repression through HNF1α. CUT&RUN mapping of HNF1α DNA-binding sites in primary human islets imputed a subset of HNF1α-regulated genes as direct targets. These data elucidate mechanistic links between HNF1A loss and diabetic phenotypes in mature human α and β cells.